Atlas Trials

Sphingomyelin Lipidosis

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Sphingomyelin Lipidosis

RecordFirmDate
A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD) (NCT04106544)Sanofi2019-09-27
Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency (NCT02004691)Genzyme, a Sanofi Company2015-12-18
Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency (NCT02292654)Genzyme, a Sanofi Company2015-05-01
A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency (NCT02004704)Genzyme, a Sanofi Company2013-12-04
Compassionate Use Program for Olipudase Alfa Enzyme Replacement Therapy for Patients With Chronic Acid Sphingomyelinase Deficiency (ASMD) (NCT04877132)Sanofi

Track Sphingomyelin Lipidosis automatically

Every clearance here is in the API, with alerts when new ones post.